Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

KCNH4 activates GD3. 1 / 1

| 1

➶

reach

"This includes the anti-idiotype vaccine, BEC-2 (administered with BCG adjuvant) targeting GD3 ganglioside, which was tested in a randomized trial as maintenance therapy in patients with limited stage SCLC, but yielded limited antibody responses against GD3 and no improvement in survival or progression-free survival [XREF_BIBR]."

21811785

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...